Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion type Assertion NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_head.
- NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion description "[Coactivators SRC-1, TIF-2, RAC3, p300, CBP, Tip60, and gelsolin are highly expressed in endocrine therapy-resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_provenance.
- NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion evidence source_evidence_literature NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_provenance.
- NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion SIO_000772 15947099 NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_provenance.
- NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion wasDerivedFrom befree-20150227 NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_provenance.
- NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_assertion wasGeneratedBy ECO_0000203 NP436913.RAPxypDmlCJmyqA96YrZYlS064eJF4dxqMbASTiGaU9Ow130_provenance.